| Literature DB >> 35646230 |
Simone Leslie1, Junmin Tan2, Prudence J McRae3, Shaun P O'leary4, Julie A Adsett1.
Abstract
Objective: To evaluate the effectiveness of exercise interventions delivered via telerehabilitation (via videoconference) for recently hospitalized adult medical patients. Data sources: A search was undertaken across six databases for English language publications from inception to May 2020.Entities:
Keywords: Exercise training; General medicine; Physical therapy; Physiotherapy; Telehealth; Telerehabilitation
Year: 2021 PMID: 35646230 PMCID: PMC9098136 DOI: 10.5195/ijt.2021.6356
Source DB: PubMed Journal: Int J Telerehabil ISSN: 1945-2020
Figure 1Flow Diagram of the Study Selection Process
Characteristics of Included Studies
| Author | Study design | Number | Mean age, years (SD) | Gender, male n (%) | Primary health condition | Disease severity | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Exp | Con | Exp | Con | Exp | Con | Exp | Con | ||||
|
| Randomized controlled trial | 24 | 29 | 68 (14) | 67 (11) | 19 (79) | 21 (72) | CHF | NYHA n (%) I | 3 (13) | 2 (7) |
| II | 9 (37) | 21 (72) | |||||||||
| III | 12 (50) | 6 (21) | |||||||||
|
| Randomized controlled trial | 49 | 49 | <60 29% | <60 33% | 28 (57) | 30 (61) | CHF | NYHA n (%) I | 11 (22) | 13 (26) |
| II | 18 (37) | 18 (37) | |||||||||
| III | 20 (41) | 18 (37) | |||||||||
|
| Pre- and posttest intervention study | 37 | - | 69.2 (8.8) | - | 5 (14) | - | COPD | FEV1, % (SD) | 27.1 (12.5) | - |
Note. CHF, Chronic Heart Failure; Con, control group; COPD, Chronic Obstructive Pulmonary Disease; Exp, experimental group; FEV1, Forced expiratory volume in 1 second; NYHA, New York Heart Association functional classification.
Summary of Included Studies
| Author | Telerehabilitation-delivered intervention via videoconference | Comparator | Duration of intervention | Follow-up duration | Outcome measures | Main findings | Attendance |
|---|---|---|---|---|---|---|---|
|
|
TR exercise: individualized exercise program, including aerobic and strength training, 60min, 2x/week (videoconferencing to groups of up to 4 participants) Other components: education; additional home exercise program, 3x/week | Centre-based inperson rehabilitation, exercise program similar to TR group | 12 weeks | 6 months (24 weeks) |
6MWD BOOMER 10MWT Grip strength Quadriceps strength MLWHFQ EQ-5D CSQ-8 |
No significant between-group difference for 6MWD (F(1.6) =1.39, p=0.24) No between-group difference for BOOMER, 10MWT, muscle strength (grip and quadriceps strength) No between-group difference for MLWHFQ and EQ-5D High levels of patient satisfaction reported with no between-group difference | Mean difference (95% CI) of sessions attended was 6 (2–9) in favor of TR |
|
|
TR exercise: Stage 1 (weeks 1-4): endurance training (walking and jogging), 40-70% HRR, 20min, 3x/week Stage 2 (weeks 5-8): endurance + resistance training (walking, jogging, calisthenics and strengthening exercises), 40-70% HRR, 30min, 5x/week Other components: education including brochure; regular follow-up via phone or consultations via instant messaging every week with cardiac nurses | Usual care (no exercise) with simple discharge education and regular follow-up at clinic | 8 weeks | 6 months |
6MWD MLWHFQ |
Significant improvement in 6MWD in telerehabilitation group. No significant change in 6MWD in control group. (Fb=21.87, p<0.001) Significant improvement in quality of life (MLWHFQ) following telerehabilitation compared to control (Fb=8.27, p=0.005). | |
|
|
TR exercise: individualized training including thoracic mobilization exercises, cardio training (60-90% max capacity), strength training (60% 1RM) and breathing exercises, 30-45min, 3x/week Other components: 1-2 TR sessions with occupational therapist; participants were asked to train on non-intervention days | No comparator | 3 weeks | - |
TUG FTSST CCQ |
Significant improvement in TUG (p<0.01) Significant improvement in FTSST (p<0.01) Significant improvement in health status (CCQ) (p=0.04) |
Note. 6MWD, 6 Minute Walk Distance; 10MWT, 10 Meter Walk Test; BOOMER, Balance Outcome Measure for Elder Rehabilitation; CCQ, Clinical COPD Questionnaire; CSQ-8, Client Satisfaction Questionnaire; EQ-5D, EuroQoL; FTSST, Five Times Sit to Stand Test; HRR, Heart rate reserve; MLWHFQ, Minnesota Living with Heart Failure Questionnaire; QoL, Quality of Life; TR, Telerehabilitation; TUG, Timed Up and Go.
| Search No. | Search Terms |
|---|---|
| #S1 | “telecare” OR “telerehab” OR “telerehabilitation” OR “telemed*” OR “telehealth” OR “videoconference” OR “internet” OR “e-health” |
| #S2 | “exercise” OR “physical activity” OR “recondition*” |
| #S3 | “physiotherapy” OR “physical therapy” |
| #S4 | “general medicine” OR “hospital*” OR “card*” OR “respir*” |
| #S5 | S1 AND S2 AND S3 AND S4 |
| #S6 | “hospital discharge” OR “hospital admission” OR “home care services, hospital-based” |
| #S7 | “pulmonary” OR “lungs” OR “lung” OR “respiratory” OR “cardiology” OR “cardiac” |
| #S8 | S1 AND S2 AND S3 AND S6 AND S7 |
| Study Aim | Main Outcome | Eligibility Criteria | Intervention | Baseline Confounders | Main Findings | Random Variability | Adverse Events | Attrition Characteristics | Probability Values | Recruitment Population | Representative Sample | Applicable Intervention | Participant Blinding | Assessor Blinding | Data Dredging | Time Period Adjustment | Statistical Analysis | Intervention Compliance | Valid Outcome Measures | Recruitment Source | Recruitment Time Period | Randomization | Allocation Concealment | Intention-to-treat Analysis | Losses to follow-up | Statistical Power | TOTAL SCORE ( / 28) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Huang et al. | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 26 |
| Peng et al. | Y | Y | Y | Y | P | Y | Y | N | N | N | N | ? | ? | N | Y | Y | Y | Y | ? | Y | Y | Y | Y | Y | Y | ? | Y | 18 |
| Minet et al. | Y | Y | Y | Y | P | Y | Y | Y | Y | N | ? | N | N | N | ? | Y | Y | Y | ? | Y | Y | Y | N | N | N | N | ? | 15 |